Ventricular fibrillation : a pediatric problem
Author(s)
Bibliographic Information
Ventricular fibrillation : a pediatric problem
（American Heart Association monograph series）
Futura Pub. Co., Inc., c2000
Available at / 5 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
A unique review of the multifaceted issues surrounding ventricular fibrillation in the pediatric patient. This is the first book ever to concentrate on the insights of numerous researchers on the often-ignored subject of pediatric ventricular fibrillation (VF). Recent advances in cardiac surgery, improved recognition of predisposing factors, ability to diagnose and treat VF by out-of-hospital and even non-medical personnel, and improved treatment regimens have all served to make pediatric VF a recognized and emerging field. This book represents a cross-fertilization of clinical research among those studying VF from different perspectives and with a variety of tools. In 10 main sections comprising 25 chapters, it defines the current knowledge of pediatric VF from the epidemiological, physiological, and clinical perspectives. It brings together examinations of the development factors at the molecular, cellular, and pathophysiological and clinical perspectives.
It brings together examinations of the developmental factors at the molecular, cellular and pathophysiological level associated with VF, and identifies questions about the clinical research and treatment of this condition that must be answered in order to save children's lives. This unique collection of chapters will interest cardiologists, pediatricians and electrophysiologists who wish to broaden their knowledge of this area.
Table of Contents
SECTION ISudden Death in the Pediatric Patient With an Ostensibly Normal Heart: Developmental Changes in Normal Substrate for Lethal Arrhythmias Chapter 1. Energetics of the Developing Heart: Implications for Understanding Ion MovementJoanne S. Ingwall, PhD Chapter 2. Developmental Changes in Innervation and Autonomic ResponsesRichard B. Robinson, PhD Chapter 3. Pediatric Animal Models of Ventricular FibrillationRobert A. Berg, MD Chapter 4. Ventricular Fibrillation in the Asphyxiated Piglet ModelVinay Nadkarni, MD SECTION IISudden Death in the Pediatric Patient With an Ostensibly Normal Heart: Developmental Expression of Lethal Arrhythmias in Children Chapter 5. Ventricular Fibrillation in Pediatric Out-of-Hospital Cardiac ArrestLinda Quan, MD Chapter 6. Ventricular Fibrillation From HypothermiaHoward M. Corneli, MD SECTION IIISudden Death in the Pediatric Patient With an Ostensibly Normal Heart: In-Hospital Ventricular Fibrillation Chapter 7. Who Will Have an Arrest In-Hospital?Arno L. Zaritsky, MD SECTION IVAt-Risk Pediatric Cardiac Populations Chapter 8. Molecular Genetics of Structural Pediatric Cardiac DiseaseCharles I. Berul, MD Chapter 9. Long QT Syndrome: Genetic AspectsJeffrey A. Towbin, MD Chapter 10. Ventricular Fibrillation in the Postoperative Cardiac PatientGeorge F. Van Hare, MD SECTION VTreatment of Pediatric Ventricular Fibrillation Chapter 11. Ion Channels and Ventricular FibrillationGlenn Wetzel, MD Chapter 12. Pediatric DefibrillationDianne L. Atkins, MD Chapter 13. Implantable Cardioverter-DefibrillatorsMichael J. Silka, MD and Jack Kron, MD SECTION VIAutomatic External Defibrillators Chapter 14. Automatic External Defibrillators: Use in the FieldRobert Delagi, MA, NREMT-P Chapter 15. The Pediatric Experience with Automatic External DefibrillatorsDianne L. Atkins, MD Chapter 16. Present Automatic External Defibrillators: Technology and Limitations for Use in the Pediatric PopulationRonald E. Stickney Chapter 17. Transthoracic Defibrillation: Waveforms and DamageRichard E. Kerber, MD Chapter 18. Automated External Defibrillators in Children: Food, Drug and Administration IssuesCarole C. Carey, RN, BSEE, MEng and Thomas J. Callahan, PhD SECTION VIIPharmacologic Treatment Chapter 19. Developmental Changes in the Cardiac Response to Pharmacologic AgentsMichael R. Rosen, MD Chapter 20. Pharmacologic Therapy of Ventricular FibrillationJames C. Perry, MD SECTION VIIIOutcomes Chapter 21. Survival Following Ventricular FibrillationMichael J. Silka, MD and John H. McAnulty, MD Chapter 22. Cost-Effectiveness of the Implantable Cardioverter-Defibrillator in the YoungRichard A. Friedman, MD and Arthur Garson Jr., MD, MPH SECTION IXPrevention Chapter 23. The Genetics of Brugada SyndromeJeffrey A. Towbin, MD Chapter 24. Syncope, Sudden Death, and Sensible ScreeningDavid J. Driscoll, MD SECTION XSummary: Where Do We Go From Here? Chapter 25. Ventricular Defibrillation in Pediatrics Research ImperativesLeon Chameides, MD
by "Nielsen BookData"
